Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-19

Clinical Trial Update: Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. [Phase 1]

View source ↗

Summary

Phase 1 study comparing safety and tolerability of the ophthalmic gel PRO-167 to Corneregel in healthy subjects with dry eye conditions; study completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corneregel
  • PRO-167

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye, Dry Eye Syndrome of Unspecified Lacrimal Gland | Phase 1 | Status: COMPLETED | Results posted: 2019-07-19